TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 82 filers reported holding TRINITY BIOTECH PLC in Q1 2014. The put-call ratio across all filers is 2.52 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $551,000 | -80.7% | 98,132 | -60.0% | 0.01% | -82.8% |
| Q1 2016 | $2,861,000 | -30.3% | 245,330 | -29.7% | 0.06% | -30.1% |
| Q4 2015 | $4,103,000 | -53.3% | 348,935 | -54.5% | 0.08% | -53.9% |
| Q3 2015 | $8,778,000 | -34.8% | 767,299 | +3.0% | 0.18% | -25.6% |
| Q2 2015 | $13,453,000 | -8.7% | 744,930 | -2.7% | 0.24% | -6.2% |
| Q1 2015 | $14,741,000 | +6.7% | 765,753 | -2.9% | 0.26% | +1.6% |
| Q4 2014 | $13,811,000 | +79.5% | 788,769 | +87.3% | 0.25% | +68.2% |
| Q3 2014 | $7,694,000 | -17.3% | 421,136 | +4.2% | 0.15% | -12.7% |
| Q2 2014 | $9,308,000 | -4.4% | 404,182 | +0.6% | 0.17% | -5.5% |
| Q1 2014 | $9,739,000 | -10.0% | 401,942 | -6.6% | 0.18% | -8.5% |
| Q4 2013 | $10,816,000 | +15.5% | 430,218 | -0.0% | 0.20% | +10.5% |
| Q3 2013 | $9,363,000 | +37.0% | 430,265 | +6.1% | 0.18% | +30.2% |
| Q2 2013 | $6,833,000 | – | 405,513 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lyon Street Capital, LLC | 639,291 | $14,723,000,000 | 6.49% |
| ACK Asset Management | 684,655 | $15,768,000 | 4.74% |
| GOLDMAN CAPITAL MANAGEMENT INC | 304,690 | $7,017,000 | 3.48% |
| Paradice Investment Management LLC | 239,138 | $5,507,000 | 1.64% |
| Park West Asset Management LLC | 520,770 | $11,993,000 | 1.56% |
| RK Capital | 323,279 | $7,445,000 | 1.48% |
| Adirondack Research & Management Inc. | 184,638 | $4,252,000 | 1.44% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 861,625 | $19,843,000 | 1.07% |
| Pier Capital, LLC | 251,917 | $5,802,000 | 0.82% |
| Benchmark Capital Advisors | 56,954 | $1,312,000 | 0.82% |